Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 497

1.

Conversion of Sox2-dependent Merkel cell carcinoma to a differentiated neuron-like phenotype by T antigen inhibition.

Harold A, Amako Y, Hachisuka J, Bai Y, Li MY, Kubat L, Gravemeyer J, Franks J, Gibbs JR, Park HJ, Ezhkova E, Becker JC, Shuda M.

Proc Natl Acad Sci U S A. 2019 Sep 16. pii: 201907154. doi: 10.1073/pnas.1907154116. [Epub ahead of print]

2.

A phase II study of the L19IL2 immunocytokine in combination with dacarbazine in advanced metastatic melanoma patients.

Weide B, Eigentler T, Catania C, Ascierto PA, Cascinu S, Becker JC, Hauschild A, Romanini A, Danielli R, Dummer R, Trefzer U, Elia G, Neri D, Garbe C.

Cancer Immunol Immunother. 2019 Sep 3. doi: 10.1007/s00262-019-02383-z. [Epub ahead of print]

PMID:
31482307
3.

Decline of PD-1 positive circulating T regulatory cells predicting more favorable clinical outcome of melanoma patients under immune checkpoint blockade.

Gambichler T, Schröter U, Höxtermann S, Susok L, Stockfleth E, Becker JC.

Br J Dermatol. 2019 Jul 30. doi: 10.1111/bjd.18379. [Epub ahead of print]

PMID:
31361026
4.

Antibiotics inhibit tumor and disease activity in cutaneous T cell lymphoma.

Lindahl LM, Willerslev-Olsen A, Gjerdrum LMR, Nielsen PR, Blümel E, Rittig AH, Celis P, Herpers B, Becker JC, Stausbøl-Grøn B, Wasik MA, Gluud M, Fredholm S, Buus TB, Johansen C, Nastasi C, Peiffer L, Kubat L, Bzorek M, Eriksen JO, Krejsgaard T, Bonefeld CM, Geisler C, Mustelin T, Langhoff E, Givskov M, Woetmann A, Kilian M, Litman T, Iversen L, Odum N.

Blood. 2019 Jul 22. pii: blood.2018888107. doi: 10.1182/blood.2018888107. [Epub ahead of print]

PMID:
31331920
5.

Successful integration of radiation oncology in preclinical medical education : Experiences with an interdisciplinary training project.

Oertel M, Schmitz M, Becker JC, Eich HT, Schober A.

Strahlenther Onkol. 2019 Jul 15. doi: 10.1007/s00066-019-01492-z. [Epub ahead of print]

PMID:
31309265
6.

MCPyV Large T antigen induced atonal homolog 1 (ATOH1) is a lineage-dependency oncogene in Merkel cell carcinoma.

Fan K, Gravemeyer J, Ritter C, Rasheed K, Gambichler T, Moens U, Shuda M, Schrama D, Becker JC.

J Invest Dermatol. 2019 Jul 5. pii: S0022-202X(19)31853-6. doi: 10.1016/j.jid.2019.06.135. [Epub ahead of print]

PMID:
31283928
7.

MERTK Acts as a Costimulatory Receptor on Human CD8+ T Cells.

Peeters MJW, Dulkeviciute D, Draghi A, Ritter C, Rahbech A, Skadborg SK, Seremet T, Carnaz Simões AM, Martinenaite E, Halldórsdóttir HR, Andersen MH, Olofsson GH, Svane IM, Rasmussen LJ, Met Ö, Becker JC, Donia M, Desler C, Thor Straten P.

Cancer Immunol Res. 2019 Sep;7(9):1472-1484. doi: 10.1158/2326-6066.CIR-18-0841. Epub 2019 Jul 2.

PMID:
31266785
8.

Uveal Melanoma: A European Network to Face the Many Challenges of a Rare Cancer.

Piperno-Neumann S, Piulats JM, Goebeler M, Galloway I, Lugowska I, Becker JC, Vihinen P, Van Calster J, Hadjistilianou T, Proença R, Caminal JM, Rogasik M, Blay JY, Kapiteijn E.

Cancers (Basel). 2019 Jun 13;11(6). pii: E817. doi: 10.3390/cancers11060817.

9.

Combination of denosumab and immune checkpoint inhibition: experience in 29 patients with metastatic melanoma and bone metastases.

Angela Y, Haferkamp S, Weishaupt C, Ugurel S, Becker JC, Oberndörfer F, Alar V, Satzger I, Gutzmer R.

Cancer Immunol Immunother. 2019 Jul;68(7):1187-1194. doi: 10.1007/s00262-019-02353-5. Epub 2019 Jun 11.

PMID:
31187176
10.

A Brief Communication on Circulating PD-1-positive T-Regulatory Lymphocytes in Melanoma Patients Undergoing Adjuvant Immunotherapy With Nivolumab.

Gambichler T, Schröter U, Höxtermann S, Susok L, Stockfleth E, Becker JC.

J Immunother. 2019 Sep;42(7):265-268. doi: 10.1097/CJI.0000000000000277.

PMID:
31145230
11.

Merkel Cell Carcinoma of the Head in a Young African Albino Woman with HIV/HTLV-1 Coinfection Associated with Multiple Squamous Cell Carcinomas.

Tenea D, Dinkel J, Becker JC, van der Walt E.

Case Rep Dermatol. 2019 Apr 30;11(1):113-122. doi: 10.1159/000499898. eCollection 2019 Jan-Apr.

12.

Metastatic Merkel cell carcinoma and myasthenia gravis: contraindication for therapy with immune checkpoint inhibitors?

Zaremba A, Chorti E, Jockenhöfer F, Bolz S, Sirin S, Glas M, Becker JC, Ugurel S, Roesch A, Schadendorf D, Livingstone E, Hagenacker T, Zimmer L.

J Immunother Cancer. 2019 May 29;7(1):141. doi: 10.1186/s40425-019-0626-9.

13.

Thin Media Images Decrease Women's Body Satisfaction: Comparisons Between Veiled Muslim Women, Christian Women and Atheist Women Regarding Trait and State Body Image.

Wilhelm L, Hartmann AS, Becker JC, Kisi M, Waldorf M, Vocks S.

Front Psychol. 2019 May 10;10:1074. doi: 10.3389/fpsyg.2019.01074. eCollection 2019.

14.

S2k-Leitlinie Merkelzellkarzinom (MZK, MCC, neuroendokrines Karzinom der Haut) - Update 2018.

Becker JC, Eigentler T, Frerich B, Gambichler T, Grabbe S, Höller U, Klumpp B, Loquai C, Krause-Bergmann A, Müller-Richter U, Pföhler C, Schneider-Burrus S, Stang A, Terheyden P, Ugurel S, Veith J, Mauch C.

J Dtsch Dermatol Ges. 2019 May;17(5):562-577. doi: 10.1111/ddg.13841_g.

PMID:
31115985
15.

S2k guidelines for Merkel cell carcinoma (MCC, neuroendocrine carcinoma of the skin) - update 2018.

Becker JC, Eigentler T, Frerich B, Gambichler T, Grabbe S, Höller U, Klumpp B, Loquai C, Krause-Bergmann A, Müller-Richter U, Pföhler C, Schneider-Burrus S, Stang A, Terheyden P, Ugurel S, Veith J, Mauch C.

J Dtsch Dermatol Ges. 2019 May;17(5):562-576. doi: 10.1111/ddg.13841. Epub 2019 May 6.

PMID:
31056838
16.

Identification of genes under dynamic post-transcriptional regulation from time-series epigenomic data.

Becker JC, Gérard D, Ginolhac A, Sauter T, Sinkkonen L.

Epigenomics. 2019 May;11(6):619-638. doi: 10.2217/epi-2018-0084. Epub 2019 May 2.

17.

MHC class-I downregulation in PD-1/PD-L1 inhibitor refractory Merkel cell carcinoma and its potential reversal by histone deacetylase inhibition: a case series.

Ugurel S, Spassova I, Wohlfarth J, Drusio C, Cherouny A, Melior A, Sucker A, Zimmer L, Ritter C, Schadendorf D, Becker JC.

Cancer Immunol Immunother. 2019 Jun;68(6):983-990. doi: 10.1007/s00262-019-02341-9. Epub 2019 Apr 16.

PMID:
30993371
18.

HDAC8 Regulates a Stress Response Pathway in Melanoma to Mediate Escape from BRAF Inhibitor Therapy.

Emmons MF, Faião-Flores F, Sharma R, Thapa R, Messina JL, Becker JC, Schadendorf D, Seto E, Sondak VK, Koomen JM, Chen YA, Lau EK, Wan L, Licht JD, Smalley KSM.

Cancer Res. 2019 Jun 1;79(11):2947-2961. doi: 10.1158/0008-5472.CAN-19-0040. Epub 2019 Apr 15.

PMID:
30987999
19.

Characterization of six Merkel cell polyomavirus-positive Merkel cell carcinoma cell lines: Integration pattern suggest that large T antigen truncating events occur before or during integration.

Schrama D, Sarosi EM, Adam C, Ritter C, Kaemmerer U, Klopocki E, König EM, Utikal J, Becker JC, Houben R.

Int J Cancer. 2019 Aug 15;145(4):1020-1032. doi: 10.1002/ijc.32280. Epub 2019 Apr 4.

PMID:
30873613
20.

A medium-throughput screen for inhibitors of human metapneumovirus.

Becker JC, Tollefson SJ, Weaver D, Williams JV.

Antivir Chem Chemother. 2019 Jan-Dec;27:2040206619830197. doi: 10.1177/2040206619830197.

21.

Neuroprotective effect of placenta-derived mesenchymal stromal cells: role of exosomes.

Kumar P, Becker JC, Gao K, Carney RP, Lankford L, Keller BA, Herout K, Lam KS, Farmer DL, Wang A.

FASEB J. 2019 May;33(5):5836-5849. doi: 10.1096/fj.201800972R. Epub 2019 Feb 12.

PMID:
30753093
22.

Decreased 5-hydroxymethylcytosine immunoreactivity in primary Merkel cell carcinoma is a strong predictor for disease-specific death.

Gambichler T, Schmitt K, Rüddel I, Dreibigacker M, Stockfleth E, Becker JC.

Br J Dermatol. 2019 Aug;181(2):389-390. doi: 10.1111/bjd.17705. Epub 2019 Apr 23. No abstract available.

PMID:
30703276
23.

[Merkel cell carcinoma].

Drusio C, Becker JC, Schadendorf D, Ugurel S.

Hautarzt. 2019 Mar;70(3):215-227. doi: 10.1007/s00105-019-4360-5. German.

PMID:
30701288
24.

[Implementation and evaluation of a revised curriculum for psychiatry and psychotherapy].

Koelkebeck K, Brouwer B, Ahrens H, Becker JC, Weih M, Marschall B, Arolt V, Ohrmann P.

Nervenarzt. 2019 Jan 29. doi: 10.1007/s00115-019-0677-7. [Epub ahead of print] German.

PMID:
30694367
25.

Genomic Landscape of Spitzoid Neoplasms Impacting Patient Management.

Hillen LM, Van den Oord J, Geybels MS, Becker JC, Zur Hausen A, Winnepenninckx V.

Front Med (Lausanne). 2018 Dec 13;5:344. doi: 10.3389/fmed.2018.00344. eCollection 2018. Review.

26.

T cell receptor fingerprinting enables in-depth characterization of the interactions governing recognition of peptide-MHC complexes.

Bentzen AK, Such L, Jensen KK, Marquard AM, Jessen LE, Miller NJ, Church CD, Lyngaa R, Koelle DM, Becker JC, Linnemann C, Schumacher TNM, Marcatili P, Nghiem P, Nielsen M, Hadrup SR.

Nat Biotechnol. 2018 Nov 19. doi: 10.1038/nbt.4303. [Epub ahead of print]

PMID:
30451992
27.

A single-arm, open-label study to assess the immunogenicity, safety, and efficacy of etanercept manufactured using the serum-free, high-capacity manufacturing process administered to patients with rheumatoid arthritis.

Polák P, Peric P, Louw I, Gaylord SM, Williams T, Becker JC, Pedersen R, Korth-Bradley J, Vlahos B.

Eur J Rheumatol. 2019 Jan;6(1):23-28. doi: 10.5152/eurjrheum.2018.18078.

28.

Pharmacological Inhibition of Serine Palmitoyl Transferase and Sphingosine Kinase-1/-2 Inhibits Merkel Cell Carcinoma Cell Proliferation.

Bhat VK, Bernhart E, Plastira I, Fan K, Ghaffari-Tabrizi-Wizsy N, Wadsack C, Rechberger G, Eichmann T, Asslaber M, Spassova I, Verhaegen ME, Malle E, Becker JC, Sattler W.

J Invest Dermatol. 2019 Apr;139(4):807-817. doi: 10.1016/j.jid.2018.10.024. Epub 2018 Nov 3.

PMID:
30399362
29.

Development and initial Experience of an online Exchange Platform on Sex and Gender Aspects in Medicine: "GenderMed-Wiki".

Schreitmüller J, Becker JC, Zsebedits D, Weskott M, Dehghan-Nayyeri M, Fegeler C, Heue M, Hochleitner M, Kindler-Röhrborn A, Pfleiderer B.

GMS J Med Educ. 2018 Aug 15;35(3):Doc32. doi: 10.3205/zma001178. eCollection 2018.

30.

Experimental Studies on State Self-Objectification: A Review and an Integrative Process Model.

Kahalon R, Shnabel N, Becker JC.

Front Psychol. 2018 Aug 13;9:1268. doi: 10.3389/fpsyg.2018.01268. eCollection 2018. Review.

31.

Molecular profiling of Spitz nevi identified by digital RNA counting.

Hillen LM, Geybels MS, Rennspiess D, Spassova I, Ritter C, Becker JC, Garmyn M, Zur Hausen A, Van den Oord J, Winnepenninckx V.

Melanoma Res. 2018 Dec;28(6):510-520. doi: 10.1097/CMR.0000000000000495.

32.

Circulating Cell-Free miR-375 as Surrogate Marker of Tumor Burden in Merkel Cell Carcinoma.

Fan K, Ritter C, Nghiem P, Blom A, Verhaegen ME, Dlugosz A, Ødum N, Woetmann A, Tothill RW, Hicks RJ, Sand M, Schrama D, Schadendorf D, Ugurel S, Becker JC.

Clin Cancer Res. 2018 Dec 1;24(23):5873-5882. doi: 10.1158/1078-0432.CCR-18-1184. Epub 2018 Jul 30.

PMID:
30061360
33.

Relational mobility predicts social behaviors in 39 countries and is tied to historical farming and threat.

Thomson R, Yuki M, Talhelm T, Schug J, Kito M, Ayanian AH, Becker JC, Becker M, Chiu CY, Choi HS, Ferreira CM, Fülöp M, Gul P, Houghton-Illera AM, Joasoo M, Jong J, Kavanagh CM, Khutkyy D, Manzi C, Marcinkowska UM, Milfont TL, Neto F, von Oertzen T, Pliskin R, San Martin A, Singh P, Visserman ML.

Proc Natl Acad Sci U S A. 2018 Jul 17;115(29):7521-7526. doi: 10.1073/pnas.1713191115. Epub 2018 Jun 29. Erratum in: Proc Natl Acad Sci U S A. 2019 Apr 16;116(16):8082.

34.

SATB1 in Malignant T Cells.

Fredholm S, Willerslev-Olsen A, Met Ö, Kubat L, Gluud M, Mathiasen SL, Friese C, Blümel E, Petersen DL, Hu T, Nastasi C, Lindahl LM, Buus TB, Krejsgaard T, Wasik MA, Kopp KL, Koralov SB, Persson JL, Bonefeld CM, Geisler C, Woetmann A, Iversen L, Becker JC, Ødum N.

J Invest Dermatol. 2018 Aug;138(8):1805-1815. doi: 10.1016/j.jid.2018.03.1526. Epub 2018 May 8.

35.

Influence of beta-blocker therapy on the risk of infections and death in patients at high risk for stroke induced immunodepression.

Maier IL, Becker JC, Leyhe JR, Schnieder M, Behme D, Psychogios MN, Liman J.

PLoS One. 2018 Apr 25;13(4):e0196174. doi: 10.1371/journal.pone.0196174. eCollection 2018.

36.

Checkpoint-Inhibitor nun auch zur Therapie des metastasierten Merkelzellkarzinoms zugelassen.

Grabbe S, Terheyden P, Becker JC.

J Dtsch Dermatol Ges. 2018 Mar;16(3):394-395. doi: 10.1111/ddg.13432. No abstract available.

PMID:
29537164
37.

The association between geographic location and incidence of Merkel cell carcinoma in comparison to melanoma: An international assessment.

Stang A, Becker JC, Nghiem P, Ferlay J.

Eur J Cancer. 2018 May;94:47-60. doi: 10.1016/j.ejca.2018.02.003. Epub 2018 Mar 20.

38.

A short-term in vivo model for Merkel Cell Carcinoma.

Bhat VK, Krump C, Bernhart E, Becker JC, Sattler W, Ghaffari-Tabrizi-Wizsy N.

Exp Dermatol. 2018 Jun;27(6):684-687. doi: 10.1111/exd.13529. Epub 2018 Mar 26.

39.

Body Covering and Body Image: A Comparison of Veiled and Unveiled Muslim Women, Christian Women, and Atheist Women Regarding Body Checking, Body Dissatisfaction, and Eating Disorder Symptoms.

Wilhelm L, Hartmann AS, Becker JC, Kişi M, Waldorf M, Vocks S.

J Relig Health. 2018 Oct;57(5):1808-1828. doi: 10.1007/s10943-018-0585-3.

PMID:
29468534
40.

S2k-Leitlinie: HPV-assoziierte Läsionen der äußeren Genitalregion und des Anus - Genitalwarzen und Krebsvorstufen der Vulva, des Penis und der peri- und intraanalen Haut (Kurzfassung).

Gross GE, Werner RN, Becker JC, Brockmeyer NH, Esser S, Hampl M, Hommel S, Jongen J, Mestel DS, Meyer T, Petry KU, Plettenberg A, Püschel K, Schneede P, Schöfer H, Sotlar K, Weyandt G, Wieland U, Wiese-Posselt M, Nast A.

J Dtsch Dermatol Ges. 2018 Feb;16(2):242-256. doi: 10.1111/ddg.13441_g. No abstract available.

PMID:
29418090
41.

S2k guideline: HPV-associated lesions of the external genital region and the anus - anogenital warts and precancerous lesions of the vulva, the penis, and the peri- and intra-anal skin (short version).

Gross GE, Werner RN, Becker JC, Brockmeyer NH, Esser S, Hampl M, Hommel S, Jongen J, Mestel DS, Meyer T, Petry KU, Plettenberg A, Püschel K, Schneede P, Schöfer H, Sotlar K, Weyandt G, Wieland U, Wiese-Posselt M, Nast A.

J Dtsch Dermatol Ges. 2018 Feb;16(2):242-255. doi: 10.1111/ddg.13441. No abstract available.

PMID:
29418083
42.

Positive stereotypes, negative outcomes: Reminders of the positive components of complementary gender stereotypes impair performance in counter-stereotypical tasks.

Kahalon R, Shnabel N, Becker JC.

Br J Soc Psychol. 2018 Apr;57(2):482-502. doi: 10.1111/bjso.12240. Epub 2018 Jan 26.

PMID:
29377186
43.

S2k-Leitlinie - Kutane Lymphome Update 2016 - Teil 2: Therapie und Nachsorge (ICD10 C82 - C86).

Dippel E, Assaf C, Becker JC, von Bergwelt-Baildon M, Beyer M, Cozzio A, Eich HT, Follmann M, Grabbe S, Hillen U, Klapper W, Klemke CD, Lamos C, Loquai C, Meiß F, Mestel D, Nashan D, Nicolay JP, Oschlies I, Schlaak M, Stoll C, Vag T, Weichenthal M, Wobser M, Stadler R.

J Dtsch Dermatol Ges. 2018 Jan;16(1):112-123. doi: 10.1111/ddg.13401_g. No abstract available.

PMID:
29314698
44.

S2k Guidelines - Cutaneous Lymphomas Update 2016 - Part 2: Treatment and Follow-up (ICD10 C82 - C86).

Dippel E, Assaf C, Becker JC, von Bergwelt-Baildon M, Beyer M, Cozzio A, Eich HT, Follmann M, Grabbe S, Hillen U, Klapper W, Klemke CD, Lamos C, Loquai C, Meiß F, Mestel D, Nashan D, Nicolay JP, Oschlies I, Schlaak M, Stoll C, Vag T, Weichenthal M, Wobser M, Stadler R.

J Dtsch Dermatol Ges. 2018 Jan;16(1):112-122. doi: 10.1111/ddg.13401. Epub 2017 Dec 27. No abstract available.

PMID:
29280595
45.

S2k-Leitlinie - Kutane Lymphome Update 2016 - Teil 1: Klassifikation und Diagnostik (ICD10 C82 - C86).

Dippel E, Assaf C, Becker JC, von Bergwelt-Baildon M, Beyer M, Cozzio A, Eich HT, Follmann M, Grabbe S, Hillen U, Klapper W, Klemke CD, Lamos C, Loquai C, Meiß F, Mestel D, Nashan D, Nicolay JP, Oschlies I, Schlaak M, Stoll C, Vag T, Weichenthal M, Wobser M, Stadler R.

J Dtsch Dermatol Ges. 2017 Dec;15(12):1266-1273. doi: 10.1111/ddg.13372_g. No abstract available.

PMID:
29228489
46.

Subcutaneous local anesthetic infusion could eliminate use of epidural analgesia after the Nuss procedure.

Kabagambe SK, Goodman LF, Chen YJ, Keller BA, Becker JC, Raff GW, Stark RA, Stephenson JT, Rahm A, Farmer DL, Hirose S.

Pain Manag. 2018 Jan;8(1):9-13. doi: 10.2217/pmt-2017-0042. Epub 2017 Dec 6.

PMID:
29210330
47.

S2k Guidelines - Cutaneous Lymphomas Update 2016 - Part 1: Classification and Diagnosis (ICD10 C82 - C86).

Dippel E, Assaf C, Becker JC, von Bergwelt-Baildon M, Beyer M, Cozzio A, Eich HT, Follmann M, Grabbe S, Hillen U, Klapper W, Klemke CD, Lamos C, Loquai C, Meiß F, Mestel D, Nashan D, Nicolay JP, Oschlies I, Schlaak M, Stoll C, Vag T, Weichenthal M, Wobser M, Stadler R.

J Dtsch Dermatol Ges. 2017 Dec;15(12):1266-1273. doi: 10.1111/ddg.13372. Epub 2017 Nov 28. No abstract available.

PMID:
29193659
48.

Epidemiology, biology and therapy of Merkel cell carcinoma: conclusions from the EU project IMMOMEC.

Becker JC, Stang A, Hausen AZ, Fischer N, DeCaprio JA, Tothill RW, Lyngaa R, Hansen UK, Ritter C, Nghiem P, Bichakjian CK, Ugurel S, Schrama D.

Cancer Immunol Immunother. 2018 Mar;67(3):341-351. doi: 10.1007/s00262-017-2099-3. Epub 2017 Nov 30. Review.

49.

Evaluation of real-world treatment outcomes in patients with distant metastatic Merkel cell carcinoma following second-line chemotherapy in Europe.

Becker JC, Lorenz E, Ugurel S, Eigentler TK, Kiecker F, Pföhler C, Kellner I, Meier F, Kähler K, Mohr P, Berking C, Haas G, Helwig C, Oksen D, Schadendorf D, Mahnke L, Bharmal M.

Oncotarget. 2017 Jul 13;8(45):79731-79741. doi: 10.18632/oncotarget.19218. eCollection 2017 Oct 3.

50.

Chemosensitivity-directed therapy compared to dacarbazine in chemo-naive advanced metastatic melanoma: a multicenter randomized phase-3 DeCOG trial.

Ugurel S, Loquai C, Terheyden P, Schadendorf D, Richtig E, Utikal J, Gutzmer R, Rass K, Sunderkötter C, Stein A, Fluck M, Kaatz M, Trefzer U, Kähler K, Stadler R, Berking C, Höller C, Kerschke L, Edler L, Kopp-Schneider A, Becker JC.

Oncotarget. 2017 Jun 27;8(44):76029-76043. doi: 10.18632/oncotarget.18635. eCollection 2017 Sep 29.

Supplemental Content

Loading ...
Support Center